Drugs with Dosage: EMULSION
✉ Email this page to a colleague
Drugs with Dosage: EMULSION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | Dosage |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heron Theraps Inc | APONVIE | aprepitant | EMULSION;INTRAVENOUS | 216457-001 | Sep 16, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | EMULSION;INTRAVENOUS | |||
| Heron Theraps Inc | APONVIE | aprepitant | EMULSION;INTRAVENOUS | 216457-001 | Sep 16, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | EMULSION;INTRAVENOUS | ||||
| Heron Theraps Inc | APONVIE | aprepitant | EMULSION;INTRAVENOUS | 216457-001 | Sep 16, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | EMULSION;INTRAVENOUS | ||||
| Heron Theraps Inc | APONVIE | aprepitant | EMULSION;INTRAVENOUS | 216457-001 | Sep 16, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | EMULSION;INTRAVENOUS | |||
| Heron Theraps Inc | APONVIE | aprepitant | EMULSION;INTRAVENOUS | 216457-001 | Sep 16, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | EMULSION;INTRAVENOUS | |||
| Heron Theraps Inc | APONVIE | aprepitant | EMULSION;INTRAVENOUS | 216457-001 | Sep 16, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | EMULSION;INTRAVENOUS | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration | >Dosage |
